You are here


Temasek leads Tropic Biosciences' US$28.5m Series B funding round

Tropic Biosciences' management team. From left: Ofir Meir, chief technology officer; Jack Peart, chief commercial officer; Gilad Gershon, chief executive officer; Eyal Maori, chief science officer.


BIOTECH startup Tropic Biosciences, which develops high-performance varieties of tropical crops, on Thursday said it has raised US$28.5 million in a Series B round of funding led by Singapore investment firm Temasek Holdings, bringing its total equity funding raised to US$40...

BT is now on Telegram!

For daily updates on weekdays and specially selected content for the weekend. Subscribe to